Product Images Apidra Solostar
View Photos of Packaging, Labels & Appearance
- Chemical Structure - apidra 01
- Figure 1A - apidra 02
- Figure 1B - apidra 03
- Figure 1C - apidra 04
- Image - apidra 05
- Figure 2 - apidra 06
- Figure 3 - apidra 07
- Figure 4 - apidra 08
- Figure - apidra 09
- Figure - apidra 10
- Figure - apidra 11
- Figure - apidra 12
- Figure - apidra 13
- Figure - apidra 14
- Figure - apidra 15
- Figure - apidra 16
- Figure - apidra 17
- Figure - apidra 18
- Figure - apidra 19
- Figure - apidra 20
- Figure - apidra 21
- Figure - apidra 22
- Figure - apidra 23
- Figure - apidra 24
- Figure - apidra 25
- PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton - apidra 26
- PRINCIPAL DISPLAY PANEL - 3 mL Pen Carton - apidra 27
Product Label Images
The following 27 images provide visual information about the product associated with Apidra Solostar NDC 0088-2502 by Sanofi-aventis U.s. Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - apidra 01
Figure 1A - apidra 02
Figure 1B - apidra 03
This text appears to be a chart related to glucose levels measured in mg/dL along with the time in hours. It also mentions APDRA and REGULAR, but it's not clear what they refer to.*
Figure 1C - apidra 04
The text provides glucose levels in mg/dL and mentions the terms aPDRA, post and REGULAR, pre. It also contains a graph with time in hours on the x-axis and glucose levels on the y-axis. However, the text is not sufficient to provide a complete description.*
Image - apidra 05
Figure 2 - apidra 06
Figure 3 - apidra 07
This is a table that shows the insulin types "GLusine" and "Regular" with corresponding time intervals of 20 to 40 minutes. The text also mentions "INSULIN" at the top.*
Figure 4 - apidra 08
Figure - apidra 09
Figure - apidra 10
Figure - apidra 11
Figure - apidra 12
Figure - apidra 13
Figure - apidra 14
Figure - apidra 15
Figure - apidra 16
Figure - apidra 17
This appears to be a physical description and diagram of a pen for injecting insulin. The diagram includes a protective seal, insulin reservoir with a window, outer and inner needle cap, dosage selector button, and rubber seal. The pen also indicates that it is designed to be used with pen needles, but these are not included in the package.*
Figure - apidra 18
Figure - apidra 19
Figure - apidra 20
Figure - apidra 21
Figure - apidra 22
Figure - apidra 23
Figure - apidra 24
Figure - apidra 25
PRINCIPAL DISPLAY PANEL - 10 mL Vial Carton - apidra 26
This is a medication called Apidra® which contains insulin glulisine for injection. Each mL has 100 IU of insulin glulisine, along with other ingredients. The package insert contains information about dosage and administration. The medication should be used cautiously and only under medical supervision. An unopened Apidra® vial should be stored refrigerated and discarded after 28 days if left at room temperature. The opened vials can be kept unrefrigerated for up to 28 days. The manufacturer is sanofi-aventis U.S. LLC. The text also includes a warning to keep the medication out of reach of children, and a GTIN number.*
PRINCIPAL DISPLAY PANEL - 3 mL Pen Carton - apidra 27
This is a description of a medical product by Sanofi for insulin glulisine injection in a disposable insulin delivery device. The product comes in a sealed carton containing five 3 mL prefilled pens and is for subcutaneous injection only. It is important to use the solution only if it is clear and colorless with no visible particles, and to use within 28 days after initial use. The product does not include needles.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
